Tag: Ajovy

Teva’s AJOVY shows promising results in migraine prevention Phase IV study

businessnewstoday- July 1, 2023

New interim analysis from the pan-European PEARL Phase IV study reveals that Teva Pharmaceutical Industries' AJOVY (fremanezumab) has led to a significant reduction in monthly ... Read More

Ajovy FDA approval : Teva’s Ajovy approved in US for migraine prevention

pharmanewsdaily- September 16, 2018

Ajovy FDA approval : Israeli pharma company Teva Pharmaceutical Industries has bagged the US Food and Drug Administration (FDA) approval for Ajovy (fremanezumab-vfrm) injection to ... Read More